Surgery is not the first-line treatment option for patients with<unk><unk><unk> . Renal transplantation is usually reserved for patients who present with undetectable circulating anti-glomerular basement antibodies in serum for 12 months and at least 6 months after stopping the use of cytotoxic agents.
Rapidly progressive glomerulonephritis surgery
Membranous glomerulonephritis surgery
IgA nephropathy surgery
Renal amyloidosis surgery
Contrast induced nephropathy medical therapy
Membranous glomerulonephritis medical therapy
Microscopic polyangiitis surgery
Focal segmental glomerulosclerosis medical therapy